Quotient Bioresearch's Management Buyout

Quotient Bioresearch raised a round of funding on January 30, 2012. Investors include Management Buyout (MBO).

Quotient Bioresearch is a provider of early stage and specialist drug development services to life science clients. The company provides tailored solutions for pharmaceutical, biotechnology and agroch…

Articles about Quotient Bioresearch's Management Buyout: